Insulin aspart, recombinant Subcutaneous and Zoledronic Acid (Zometa)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Zoledronic Acid (Zometa) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic acid, Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Zoledronic Acid Injection
- Insulin aspart, recombinant Subcutaneous-Zoledronic Acid Injection Concentrate
- Insulin aspart, recombinant Subcutaneous-Zoledronic acid Intravenous
- Insulin aspart, recombinant Subcutaneous-Zoledronic Acid IV
- Insulin aspart, recombinant Subcutaneous-Zolgensma
- Insulin aspart, recombinant Subcutaneous-Zolinza
- Zoledronic Acid (Zometa)-Insulin degludec
- Zoledronic Acid (Zometa)-Insulin Degludec (U-100) Prefilled Pens
- Zoledronic Acid (Zometa)-Insulin Degludec (U-100) Vials
- Zoledronic Acid (Zometa)-Insulin Degludec (U-200) Prefilled Pens
- Zoledronic Acid (Zometa)-Insulin degludec and liraglutide
- Zoledronic Acid (Zometa)-Insulin degludec and liraglutide Subcutaneous